Differential Inhibition of CYP17A1 and CYP21A2 Activities by the P450 Oxidoreductase Mutant A287P
Open accessAbstract
P450 oxidoreductase (POR) has a pivotal role in facilitating electron transfer from nicotinamide adenine dinucleotide phosphate to microsomal cytochrome P450 (CYP) enzymes, including the steroidogenic enzymes CYP17A1 and CYP21A2. Mutations in POR have been shown recently to cause congenital adrenal hyperplasia with apparent combined CYP17A1 and CYP21A2 deficiency that comprises a variable clinical phenotype, including glucocorticoid deficiency, ambiguous genitalia, and craniofacial malformations. To dissect structure-function relationships potentially explaining this phenotypic diversity, we investigated whether specific POR mutations have differential effects on CYP17A1 and CYP21A2. We compared the impact of missense mutations encoding for single amino acid changes in three distinct regions of the POR molecule: 1), Y181D and H628P close to the central electron transfer area, 2) S244C located within the hinge close to the flavin adenine dinucleotide and flavin mononucleotide domains of POR, and 3) A287P that is clearly distant from the two other regions. Functional analysis using a yeast microsomal assay with coexpression of human CYP17A1 or CYP21A2 with wild-type or mutant human POR revealed equivalent decreases in CYP17A1 and CYP21A2 activities by Y181D, H628P, and S244C. In contrast, A287P had a differential inhibitory effect, with decreased catalytic efficiency (Vmax/Km) for CYP17A1, whereas CYP21A2 retained near normal activity. In vivo analysis of urinary steroid excretion by gas chromatography/mass spectrometry in 11 patients with POR mutations showed that A287P homozygous patients had the highest corticosterone/cortisol metabolite ratios, further indicative of preferential inhibition of CYP17A1. These findings provide novel mechanistic insights into the redox regulation of human steroidogenesis. Differential interaction of POR with electron-accepting CYP enzymes may explain the phenotypic variability in POR deficiency, with additional implications for hepatic drug metabolism by POR-dependant CYP enzymes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In a previous study, patients with homozygous p.A287P had significantly increased corticosterone over cortisol metabolite ratios.
“We have demonstrated this in a previous study by describing significantly increased corticosterone over cortisol metabolite ratios in patients with homozygous p.A287P (21).”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [21]
In vitro findings indicated a significantly higher impairment of 17α-hydroxylase over 21-hydroxylase for p.A287P.
“These in vivo findings were entirely consistent with the in vitro findings that indicated a significantly higher impairment of 17α-hydroxylase over 21-hydroxylase for p.A287P (21).”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [21]
p.A287P causes predominant 17α-hydroxylase over 21-hydroxylase impairment.
“We previously demonstrated predominant 17α-hydroxylase over 21-hydroxylase impairment by p.A287P (21), and indeed, arterial hypertension has been documented in homozygous carriers (3, 12), probably caused by excess deoxycorticosterone production as in classical 17α-hydroxylase deficiency.”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [21]
Cites
The Carbon Monoxide-binding Pigment of Liver Microsomes
Omura, T., & Sato, R. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82244-3 · Cited by 11,781 · see citing works
Improved method for high efficiency transformation of intact yeast cells.
Gietz, D., Jean, A. S., Woods, R. A., & Schiestl, R. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.6.1425 · Cited by 3,379 · see citing works
Congenital Adrenal Hyperplasia
Speiser, P., & White, P. C. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409 · see citing works
Wang, M., Roberts, D. L., Paschke, R., Shea, T. M., Masters, B. S. S., & Kim, J.-J. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8411 · Cited by 744 · see citing works
[6] Yeast expression of animal and plant P450s in optimized redox environments
Pompon, D., Louërat-Oriou, B., Bronine, A., & Urban, P. (1996) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(96)72008-6 · Cited by 654 · see citing works
Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541 · see citing works
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509 · see citing works
Self-citationArlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16503-3 · Cited by 345 · see citing works
Self-citationHuang, N., Pandey, A. V., Agrawal, V., Reardon, W., Lapunzina, P. D., Mowat, D., Jabs, E. W., Vliet, G. V., Sack, J., Flück, C. E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429417 · Cited by 336 · see citing works
The genetic and functional basis of isolated 17,20 lyase deficiency
Geller, D. H., Auchus, R. J., Mendonça, B. B., & Miller, W. L. (1997) · Nature Genetics · doi:10.1038/ng1097-201 · Cited by 318 · see citing works
Shen, A. L., Porter, T. D., Wilson, T. E., & Kasper, C. B. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83274-4 · Cited by 264 · see citing works
Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research
Shackleton, C. H. L. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90132-g · Cited by 247 · see citing works
Self-citationArlt, W., Auchus, R. J., & Miller, W. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100040200 · Cited by 157 · see citing works
Self-citationFukami, M., Horikawa, R., Nagai, T., Tanaka, T., Naiki, Y., Sato, N., Okuyama, T., Nakai, H., Soneda, S., Tachibana, K., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0810 · Cited by 155 · see citing works
Peterson, R. E., Imperato-McGinley, J., Gautier, T., & Shackleton, C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511073131903 · Cited by 148 · see citing works
Self-citationDissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains.
Smith, G. C., Tew, D. G., & Wolf, C. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8710 · Cited by 136 · see citing works
Caulfield, M. P., Lynn, T., Gottschalk, M. E., Jones, K. L., Taylor, N. F., Malunowicz, E. M., Shackleton, C. H. L., Reitz, R. E., & Fisher, D. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8712 · Cited by 120 · see citing works
Self-citationAdachi, M., Tachibana, K., Asakura, Y., Yamamoto, T., Hanaki, K., & Oka, A. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30169 · Cited by 110 · see citing works
Biochemical diagnosis of Antley–Bixler syndrome by steroid analysis
Shackleton, C. H. L., Marcos, J., Małunowicz, E., Szarras‐Czapnik, M., Jira, P. E., Taylor, N., Murphy, N., Crushell, E., Gottschalk, M. E., Hauffa, B. P., et al. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30104 · Cited by 86 · see citing works
Self-citation5α-Reduced C21 steroids are substrates for human cytochrome P450c17
Gupta, M. K., Guryev, O. L., & Auchus, R. J. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.07.003 · Cited by 84 · see citing works
An efficient chloramphenicol-resistance marker for Saccharomyces cerevisiae and Escherichia coli
Hadfield, C., Cashmore, A. M., & Meacock, P. A. (1986) · Gene · doi:10.1016/0378-1119(86)90249-0 · Cited by 73 · see citing works
Walker, E. A., Clark, A. M., Hewison, M., Ride, J. P., & Stewart, P. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011142200 · Cited by 65 · see citing works
Self-citationSex Steroid Metabolism in Human Peripheral Blood Mononuclear Cells Changes with Aging
Hammer, F., Drescher, D. G., Schneider, S. B., Quinkler, M. O., Stewart, P. M., Allolio, B., & Arlt, W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0915 · Cited by 37 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Disorders of sex development: a new definition and classification
Hughes, I. A. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.11.001 · Cited by 440 · see citing works
NADPH P450 oxidoreductase: Structure, function, and pathology of diseases
Pandey, A. V., & Flück, C. E. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.010 · Cited by 279 · see citing works
Steroidogenesis: Unanswered Questions
Miller, W. L. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.09.002 · Cited by 226 · see citing works
Huang, N., Agrawal, V., Giacomini, K. M., & Miller, W. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711621105 · Cited by 198 · see citing works
Congenital Adrenal Hyperplasia
Witchel, S. F. (2017) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2017.04.001 · Cited by 187 · see citing works
Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency
Krone, N., Reisch, N., Idkowiak, J., Dhir, V., Ivison, H. E., Hughes, B. A., Rose, I. T., O'Neil, D. M., Vijzelaar, R., Smith, M. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0640 · Cited by 163 · see citing works
Self-citationCongenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2011) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2010.10.001 · Cited by 147 · see citing works
MECHANISMS IN ENDOCRINOLOGY: Rare defects in adrenal steroidogenesis
Miller, W. L. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0279 · Cited by 138 · see citing works
Gomes, A. M., Winter, S., Klein, K., Turpeinen, M., Schaeffeler, E., Schwab, M. G., & Zanger, U. M. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.7 · Cited by 125 · see citing works
Fukami, M., Nishimura, G., Homma, K., Nagai, T., Hanaki, K., Uematsu, A., Ishii, T., Numakura, C., Sawada, H., Nakacho, M., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2816 · Cited by 117 · see citing works
Agrawal, V., Huang, N., & Miller, W. L. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32830054ac · Cited by 117 · see citing works
Pharmacogenomics of human P450 oxidoreductase
Pandey, A. V., & Sproll, P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00103 · Cited by 92 · see citing works
Clinical, genetic and enzymatic characterization of P450 oxidoreductase deficiency in four patients
Sahakitrungruang, T., Huang, N., Tee, M. K., Agrawal, V., Russell, W. E., Crock, P., Murphy, N., Migeon, C. J., & Miller, W. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1460 · Cited by 82 · see citing works
P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms
Burkhard, F. Z., Parween, S., Udhane, S. S., Flück, C. E., & Pandey, A. V. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.04.003 · Cited by 79 · see citing works
Tomalik-Scharte, D., Maiter, D., Kirchheiner, J., Ivison, H. E., Fuhr, U., & Arlt, W. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0764 · Cited by 77 · see citing works
Self-citationEffects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro
Sandee, D., Morrissey, K., Agrawal, V., Tam, H. K., Kramer, M. A., Tracy, T. S., Giacomini, K. M., & Miller, W. L. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833f4f9b · Cited by 74 · see citing works
Prenatal diagnosis of congenital adrenal hyperplasia caused by P450 oxidoreductase deficiency
Reisch, N., Idkowiak, J., Hughes, B. A., Ivison, H. E., Abdul-Rahman, O. A., Hendon, L. G., Olney, A. H., Nielsen, S., Harrison, R., Blair, E. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3449 · Cited by 67 · see citing works
Self-citationIdkowiak, J., O'Riordan, S., Reisch, N., Malunowicz, E. M., Collins, F., Kerstens, M. N., Köhler, B., Graul-Neumann, L. M., Szarras-Czapnik, M., Dattani, M., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1607 · Cited by 64 · see citing works
Self-citationP450 oxidoreductase: genetic polymorphisms and implications for drug metabolism and toxicity
Hart, S. N., & Zhong, X.-B. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.4.439 · Cited by 62 · see citing works
Flück, C. E., Mullis, P. E., & Pandey, A. V. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.035 · Cited by 59 · see citing works
P450 oxidoreductase deficiency: a new form of congenital adrenal hyperplasia
Flück, C. E., & Miller, W. L. (2006) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000236395.71956.5c · Cited by 57 · see citing works
The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency
Gomes, L. G., Huang, N., Agrawal, V., Mendonça, B. B., Bachega, T. A. S. S., & Miller, W. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0304 · Cited by 52 · see citing works
Xi, B., Shen, Y. L., Reilly, K. H., Wang, X., & Mi, J. (2012) · Metabolism · doi:10.1016/j.metabol.2012.07.008 · Cited by 52 · see citing works
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Wiley eBooks · doi:10.1002/9781444316728.ch13 · Cited by 51 · see citing works
Clinical and Biochemical Consequences of P450 Oxidoreductase Deficiency
Flück, C. E., & Pandey, A. V. (2010) · Endocrine development · doi:10.1159/000321221 · Cited by 50 · see citing works
Kranendonk, M., Marohnic, C. C., Panda, S. P., Duarte, M. P., Oliveira, J. S., Masters, B. S. S., & Rueff, J. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.04.014 · Cited by 50 · see citing works
Marohnic, C. C., Panda, S. P., McCammon, K. M., Rueff, J., Masters, B. S. S., & Kranendonk, M. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.030445 · Cited by 49 · see citing works
Restoration of mutant cytochrome P450 reductase activity by external flavin
Nicolo, C., Flück, C. E., Mullis, P. E., & Pandey, A. V. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.02.024 · Cited by 49 · see citing works
Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study
García‐Giralt, N., Rodríguez-Sanz, M., Prieto‐Alhambra, D., Servitja, S., del Pliego, E. T., Balcells, S., Albanell, J., Grinberg, D., Díez‐Pérez, A., Tusquets, I., et al. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2638-3 · Cited by 48 · see citing works
Chen, X., Pan, L. Q., Naranmandura, H., Zeng, S., & Chen, S. Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038495 · Cited by 46 · see citing works
Dhir, V., Reisch, N., Bleicken, C., Lebl, J., Kamrath, C., Schwarz, H., Grötzinger, J., Sippell, W. G., Riepe, F. G., Arlt, W., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0172 · Cited by 46 · see citing works
Self-citationDean, B., Chrisp, G. L., Quartararo, M., Maguire, A. M., Hameed, S., King, B. R., Munns, C. F., Torpy, D. J., Falhammar, H., & Rushworth, R. L. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz255 · Cited by 43 · see citing works
Subramanian, M., Agrawal, V., Sandee, D., Tam, H. K., Miller, W. L., & Tracy, T. S. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283544062 · Cited by 43 · see citing works
Diagnosis and Treatment of Disorders of Sexual Development
Rey, R. A., & Josso, N. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00119-0 · Cited by 40 · see citing works
Impact on CYP19A1 activity by mutations in NADPH cytochrome P450 oxidoreductase
Flück, C. E., & Pandey, A. V. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.031 · Cited by 39 · see citing works
Parween, S., Roucher-Boulez, F., Flück, C. E., Lienhardt-Roussie, A., Mallet, D., Morel, Y., & Pandey, A. V. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1928 · Cited by 37 · see citing works
Age-specific changes in sex steroid biosynthesis and sex development
Krone, N., Hanley, N. A., & Arlt, W. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.06.001 · Cited by 36 · see citing works
Self-citationLi, H., Zhao, A., Xie, M., Chen, L., Wu, H., Shen, Y., & Wang, H. (2021) · Translational Pediatrics · doi:10.21037/tp-21-499 · Cited by 34 · see citing works
Cytochrome P450 Oxidoreductase Deficiency
Idkowiak, J., Cragun, D. L., Hopkin, R. J., & Arlt, W. (2009) · University of Washington, Seattle eBooks · Cited by 33 · see citing works
Self-citationMoutinho, D., Marohnic, C. C., Panda, S. P., Rueff, J., Masters, B. S. S., & Kranendonk, M. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.042820 · Cited by 31 · see citing works
P450 oxidoreductase deficiency and Antley–Bixler syndrome
Arlt, W. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9056-y · Cited by 31 · see citing works
Self-citationKoyama, Y., Homma, K., Fukami, M., Miwa, M., Ikeda, K., Ogata, T., Hasegawa, T., & Murata, M. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.173286 · Cited by 30 · see citing works
Idkowiak, J., Małunowicz, E., Dhir, V., Reisch, N., Szarras‐Czapnik, M., Holmes, D. M., Shackleton, C. H. L., Davies, J. D., Hughes, I. A., Krone, N. P., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0058 · Cited by 30 · see citing works
Self-citationModeling of human P450 oxidoreductase structure by in silico mutagenesis and MD simulation
Flück, C. E., Mullis, P. E., & Pandey, A. V. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.001 · Cited by 30 · see citing works
Velazquez, M. N. R., Parween, S., Udhane, S. S., & Pandey, A. V. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.127 · Cited by 26 · see citing works
Song, T., Wang, B., Chen, H., Zhu, J., & Sun, H. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1393663 · Cited by 24 · see citing works
Marohnic, C. C., Huber, W. J., Connick, J. P., Reed, J. R., McCammon, K. M., Panda, S. P., Pavel Martasek, E., Backes, W. L., & Masters, B. S. S. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.06.008 · Cited by 22 · see citing works
Bonamichi, B. D. S. F., Santiago, S. L. M., Bertola, D. R., Kim, C. A., Alonso, N., Mendonca, B. B., Bachega, T. A. S. S., & Gomes, L. G. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000213 · Cited by 19 · see citing works
Tomková, M., Marohnic, C. C., Gurwitz, D., Šeda, O., Masters, B. S. S., & Pavel Martasek, E. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.21 · Cited by 17 · see citing works
Bleicken, C., Loidi, L., Dhir, V., Parajes, S., Quinteiro, C., Dominguez, F., Grötzinger, J., Sippell, W. G., Riepe, F. G., Arlt, W., et al. (2009) · Human Mutation · doi:10.1002/humu.20926 · Cited by 15 · see citing works
Self-citationA sex-specific effect of the CYP17A1 SNP rs11191548 on blood pressure in Chinese children
Wu, L., Xi, B., Zhang, M., Shen, Y. L., Zhao, X., Wang, T., Cheng, H., Hou, D., Liu, G., Wang, X., et al. (2011) · Journal of Human Hypertension · doi:10.1038/jhh.2011.96 · Cited by 15 · see citing works
The Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 14 · see citing works
Delayed diagnosis of disorder of sex development (DSD) due to P450 oxidoreductase (POR) deficiency
Koika, V., Armeni, A. K., & Georgopoulos, N. A. (2016) · HORMONES · doi:10.14310/horm.2002.1679 · Cited by 12 · see citing works
A rare cause of congenital adrenal hyperplasia: Antley-Bixler syndrome due to POR deficiency.
Herkert, J. C., Blaauwwiekel, E. E., Hoek, A., Veenstra‐Knol, H. E., Kema, I. P., Arlt, W., & Kerstens, M. N. (2011) · PubMed · Cited by 12 · see citing works
Self-citationP450 Oxidoreductase Deficiency (PORD)
Flück, C. E., & Pandey, A. V. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00010-7 · Cited by 7 · see citing works
Diagnosis and Treatment of Disorders of Sexual Development
Rey, R. A., Josso, N., & Forest, M. G. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00119-2 · Cited by 6 · see citing works
Jin, Y., Chen, M., Penning, T. M., & Miller, W. L. (2015) · Biochemical Journal · doi:10.1042/bj20141410 · Cited by 6 · see citing works
Reisch, N., Auchus, R. J., Shackleton, C. H. L., Hanley, N. A., & Arlt, W. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007695117 · Cited by 5 · see citing works
Self-citationWu, L., Gao, L., Zhao, X., Zhang, M., Wu, J., & Mi, J. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0523-y · Cited by 5 · see citing works
POR polymorphisms are associated with 21 hydroxylase deficiency
Giraldi, F. P., Einaudi, S., Sesta, A., Verna, F., Messina, M., Manieri, C., Menegatti, E., & Ghizzoni, L. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01527-2 · Cited by 5 · see citing works
Flück, C. E. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8002-1_1 · Cited by 5 · see citing works
Ahmed, S., Zhou, J., Zhou, Z. M., & Chen, S.-Q. (2018) · Genes · doi:10.3390/genes9100514 · Cited by 4 · see citing works
Baranowski, E. S., Idkowiak, J., Waterson, J. R., DʼHarlingue, A. E., Olney, A. H., Ivison, H., Hughes, B., Mueller, J., Arlt, W., & Shackleton, C. H. L. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106760 · Cited by 3 · see citing works
Self-citationBarata, L. A., Fioretto, M. N., Felipe, V. A. D. A., de Souza, P. V., Ribeiro, I. T., Maciel, F. A., Portela, L. M. F., Moreira, M. F., Cordeiro, G. M., Vieira, A. D. F. P., et al. (2025) · Archives of Medical Research · doi:10.1016/j.arcmed.2025.103334 · Cited by 2 · see citing works
Liu, X., Low, S., & Boddy, A. V. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1196189 · Cited by 2 · see citing works
P450 oxidoreductase deficiency
Flück, C. E., Velazquez, M. N. R., & Pandey, A. V. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00012-5 · Cited by 3 · see citing works
Velazquez, M. N. R., Parween, S., Udhane, S. S., & Pandey, A. V. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/640540 · Cited by 2 · see citing works
Genetic Defects of Female Sexual Differentiation
Cools, M., der Grinten, H. L. C., Baere, E. D., Callens, N., & Dessens, A. B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00068-7 · Cited by 1 · see citing works
Molecular Genetics of Congenital Adrenal Hyperplasia
Parajes, S., & Krone, N. P. (2012) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0023590 · Cited by 1 · see citing works
Self-citationGomes, L. G. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2009.tde-09122009-152831
Genetic Defects of Female Sexual Differentiation
Dessens, A. B., Cools, M., Richter-Unruh, A., Looijenga, L. H. J., Grootegoed, J. A., & Drop, S. L. S. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00101-7
Shackleton, L., Davies, J. D., Hughes, I. A., Krone, N. P., Arlt, W., Idkowiak, J., Małunowicz, E., Dhir, V., Reisch, N., Szarras‐Czapnik, M., et al. (2010)
Self-citationPrenatal diagnosis of congenital adrenal hyperplasia caused by P450 oxidoreductase
Haskins, A., & Arlt, W. (2015)
Self-citationFarmakokinetisk betydning av sekvensvarianter i CYP3A4, CYP3A5, POR og PPARA
Dahl, M. (2013) · NORA - Norwegian Open Research Archives
Dean, B. W., Chrisp, G. L., Quartararo, M., Maguire, A. M., Hameed, S. S., Br, K., Munns, C. F., Torpy, D. J., Falhammar, H., & Rushworth, R. L. (2020) · Yearbook of pediatric endocrinology · doi:10.1530/ey.17.8.21 · Cited by 1 · see citing works
Disorders of Adrenal Steroid Biosynthesis Defects
He, X., & Auchus, R. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-822563-9.00216-x
Demirel, O. B., Yıldız, M., Küçükgergin, C., Karaman, V., Kılınç, S., Arık, S. D., Gedikbaşı, A., Yıldırım, Z. Y., Ayaz, N. A., Toksoy, G., et al. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag030
Szklarz, M., Wołos-Kłosowicz, K., Szulc, J., Górny, J. M., & Matuszewski, W. (2026) · Middle East Fertility Society Journal · doi:10.1186/s43043-026-00364-8
- Authors
- Dhir, V., Ivison, H. E., Krone, N., Shackleton, C. H. L., Doherty, A. J., Stewart, P. M., & Arlt, W.
- Affiliations
- University of Birmingham (GB)
- University of Sussex (GB)
- Corresponding author
- Arlt, Wiebke
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2007-08-01
- Volume
- 21
- Issue
- 8
- Pages
- 1958-1968
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- OpenAlex
- W2009818733
- Cited by
- 78
- References
- 23
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 1 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 7 · 2015: 3 · 2014: 1 · 2013: 5 · 2012: 7
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Molecular Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- cytochrome P450 oxidoreductase, CYP17A1, CYP21A2, congenital adrenal hyperplasia, steroidogenesis, electron transfer, flavin adenine dinucleotide, flavin mononucleotide, catalytic efficiency, phenotypic variability, hepatic drug metabolism
- MeSH terms
- Alanine, Amino Acid Sequence, Animals, Humans, Molecular Sequence Data, NADPH-Ferrihemoprotein Reductase, Proline, Rabbits, Steroid 17-alpha-Hydroxylase, Steroid 21-Hydroxylase, Amino Acid Substitution, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review